Symbols

SRTA

Strata·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SRTA

Strata Critical Medical, Inc.

Technology driven air travel company

Industry

Air Cargo and Logistics

Established Date

12/22/2014

Listing Date

11/05/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

327

Fiscal Year Ends

12-31

Website

ir.stratacritical.com

Security Type

Common stock

Office address

31 Hudson Yards 14th Floor New York NY 10001

Business

Introduction

Strata Critical Medical, Inc., was incorporated in Delaware on December 22, 2014. The company is a time-critical logistics and medical service provider for the US healthcare industry. The company operates one of the nation's largest air and surgical service networks for transplant hospitals and organ procurement organizations, providing an integrated "one phone" solution for donor organ recovery. Strata operates in two operating segments: logistics and clinical, providing a variety of logistics and clinical services related to organ transplantation and the broader healthcare industry. Strata's core services include air and ground logistics, organ placement, surgical organ recovery, normal temperature regional perfusion and preservation in the transplant industry, As well as perfusion staffing and equipment solutions for cardiovascular surgery centers under the brands Trinity Medical Solutions (" Trinity ") and Keystone Perfusion Services LLC (" Keystone ").

Company Financials

EPS

SRTA has released its 2025 Q4 earnings. EPS was reported at -0.06, versus the expected -0.04, missing expectations. The chart below visualizes how SRTA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SRTA has released its 2025 Q4 earnings report, with revenue of 66.79M, reflecting a YoY change of 83.54%, and net profit of -8.83M, showing a YoY change of 9.80%. The Sankey diagram below clearly presents SRTA's revenue sources and cost distribution.